Related Experiment Video
Updated: Aug 6, 2026
08:27
Synthesis and Characterization of mRNA-Loaded Poly(Beta Aminoesters) Nanoparticles for Vaccination Purposes
Published on: August 13, 2021
DNA-based vaccines: Advances, applications, and future prospects
Zhichang Peter Zhou1,2, Ziyan Rachel Chen1,3, Ranmal Avinash Bandara1,3
1Translational Medicine Program, Hospital for Sick Children Research Institute, Toronto, Ontario M5G 0A4, Canada.
Genes & Diseases
|July 23, 2026
Summary
DNA vaccines offer a stable, adaptable platform for immunization against infectious diseases and cancers. Innovations are improving their effectiveness in humans, marking a significant step for global health.
Area of Science:
- Immunology
- Vaccinology
- Molecular Biology
Background:
- DNA vaccines utilize engineered DNA to induce immune responses, mimicking natural infection.
- They offer advantages like stability, ease of manufacturing, and potential for long-lasting immunity.
- Challenges remain in achieving robust human immunogenicity despite success in animal models.
Purpose of the Study:
- To review the advancements and potential of DNA-based vaccines.
- To highlight innovations addressing immunogenicity limitations.
- To discuss the expanding applications in infectious diseases, cancer, and autoimmune disorders.
Main Methods:
- Review of scientific literature on DNA vaccine technology.
- Analysis of clinical trial data and veterinary approvals.
- Discussion of recent technological innovations in DNA vaccine development.
Main Results:
- DNA vaccines have shown success in animal models and for specific human diseases like Ebola and COVID-19.
- Recent innovations focus on delivery systems, adjuvants, and vector optimization.
- Approved veterinary DNA vaccines and human applications demonstrate growing utility.
Conclusions:
- DNA-based vaccines represent a promising next-generation platform for diverse diseases.
- Continued research is crucial for overcoming immunogenicity challenges and expanding global health applications.
- Technological refinements are enhancing the safety and efficacy of DNA vaccines.
Related Concept Videos
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:20The Central Dogma
The central dogma explains the flow of genetic information from DNA nucleotides to the amino acid sequence of proteins.
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
03:00Next-generation Sequencing
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:09Recombinant DNA
Overview